Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Carcinoma, Non-Small-Cell Lung 4 Pancreatic Neoplasms 3 Squamous Cell Carcinoma of Head and Neck 2 Uterine Cervical Neoplasms 1 Rectal Neoplasms 1 Neoplasms 1 Muscle Invasive Bladder Cancer 1 Laryngeal Neoplasms 1 Laryngeal Diseases 1 Inoperable œsophageal Cancer 1 Head and Neck Neoplasms 1 Esophageal Squamous Cell Carcinoma 1 Esophageal Neoplasms 1 Carcinoma, Squamous Cell 1 Adenocarcinoma Of Esophagus 1

Interventions

Nivolumab 1 Ipilimumab 1 Chemoradiotherapy 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Terminated × Inoperable œsophageal Cancer × Chemoradiotherapy × Clear all

NCT03437200 2023-02-21

CRUCIAL

European Organisation for Research and Treatment of Cancer - EORTC

Phase 2 Terminated

Inoperable œsophageal Cancer

Data powered by HemOnc (CC BY 4.0) Colophon ⚡